Skip to main content
Table of Contents
Print

Are There Cardiovascular Risks with Cannabis in Anxiety Patients? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

While cannabis is commonly used to manage anxiety, however, potential cannabis’ cardiovascular risks in anxiety patients may exist. Understanding these risks is essential for ensuring safe use. Examining heart rate changes, blood pressure effects, and overall cardiac safety helps clinicians and patients make informed decisions about cannabis therapy. 

Recognising Cardiovascular Concerns 

Awareness of cannabis and cardiovascular risks in anxiety supports safer treatment and proactive monitoring. 

Heart Rate Changes 

Cannabis can induce heart rate changes, including tachycardia or palpitations, which may be more pronounced in anxiety patients or those with underlying heart conditions. 

Blood Pressure Effects 

Blood pressure effects may include transient increases or decreases, potentially affecting individuals sensitive to hemodynamic fluctuations. Monitoring is advised to maintain stability during cannabis use. 

Cardiac Safety 

Evaluating cardiac safety is critical for patients with pre-existing cardiovascular conditions. Clinicians should assess overall risk before recommending cannabis and provide guidance on safe consumption methods. 

Preventive Measures 

Patients can reduce cannabis’ cardiovascular risks in anxiety by starting with low doses, avoiding high-THC products, and regularly monitoring vital signs. Professional guidance ensures safe integration into treatment plans. 

Understanding cannabis’ cardiovascular risks in anxiety, including heart rate changes, blood pressure effects, and cardiac safety, allows patients and clinicians to balance therapeutic benefits with potential cardiovascular concerns. 

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories